Loss of programmed cell death 4 induces apoptosis by promoting the translation of procaspase-3 mRNA

Cell Death and Differentiation

Volumn 19, Issue 4, 2012, Pages 573-581

  Eto, K ^a   Goto, S ^a   Nakashima, W ^a   Ura, Y ^a   Abe, S I ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

caspase 3; microRNA; Pdcd4; translational control

Indexed keywords

CASPASE 3; CELL PROTEIN; MESSENGER RNA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROCASPASE 3; PROGRAMMED CELL DEATH 4; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL NUCLEUS; ENZYME ACTIVATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CASPASE 3; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HELA CELLS; HUMANS; PROTEIN BIOSYNTHESIS; RNA, MESSENGER; RNA-BINDING PROTEINS;

EID: 84858159991     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2011.126     Document Type: Article

References (36)

1. Strasser A, Harris AW, Bath ML, Cory S. Novel primitive lymphoid tumors induced in transgenic mice by cooperation between myc and bcl-2. Nature 1990; 348: 331-333. (Pubitemid 120029100)
2. McDonnell TJ, Korsmeyer SJ. Progression from lymphoid hyperplasia to high grade malignant lymphoma in mice transgenic for the t(14; 18). Nature 1991; 349: 254-256. (Pubitemid 21912060)
3. Strasser A, Whittingham S, Vaux DL, Bath ML, Adams JM, Cory S et al. Enforced BCL2 expression in B lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc Natl Acad Sci USA 1991; 88: 8661-8665. (Pubitemid 21915417)
4. Watanabe-Fukunaga R, Brannan CL, Copeland NG, Jenkins NA, Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992; 356: 314-317.
5. Barr PJ, Tomei LD. Apoptosis and its role in human disease. Biotechnology 1994; 12: 487-493.
6. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995; 267: 1456-1462.
7. Strasser A, O'Connor L, Dixit VM. Apoptosis signaling. Annu Rev Biochem 2000; 69: 217-245.
8. Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG, Eamshaw WC. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 1994; 371: 346-347. (Pubitemid 24300618)
9. Shibahara K, Asano M, Ishida Y, Aoki T, Koike T, Honjyo T. Isolation of a novel mouse gene MA-3 that is induced upon programmed cell death. Gene 1995; 166: 297-301.
10. Onishi Y, Hashimoto S, Kizaki H. Cloning of the TIS gene suppressed by topoisomerase inhibitors. Gene 1998; 215: 453-459. (Pubitemid 28382949)
11. Azzoni L, Zatsepina O, Abebe B, Bennett IM, Kanakaraj P, Perussia B. Differential transcriptional regulation of CD161 and a novel gene, 199/15a, by IL-2, IL-15, and IL-12 in NK and T cells. J Immunol 1998; 161: 3493-3500.
12. Matsuhashi S, Yoshinaga H, Yatsuki H, Tsugita A, Hori K. Isolation of a novel gene from a human cell line with Pr-28mAb which recognizes a nuclear antigen involved in the cell cycle. Res Commun Biochem Cell Mol Biol 1997; 1: 109-120.
13. Göke A, Göke R, Knolle A, Trusheim H, Schmidt H, Wilmen A et al. DUG is a novel homologue of translation initiation factor 4G that binds eIF4A. Biochem Biophys Res Commun 2002; 297: 78-82.
14. Onishi Y, Kizaki H. Molecular cloning of the genes suppressed in RVC lymphoma cells by topoisomerase inhibitors. Biochem Biophys Res Commun 1996; 228: 7-13. (Pubitemid 26390624)
15. Lankat-Buttgereit B, Göke R. The tumour suppressor Pdcd4: recent advances in the elucidation of function and regulation. Biol Cell 2009; 101: 309-317.
16. Allgayer H. Pdcd4, a colon cancer prognostic that is regulated by a microRNA. Crit Rev Oncol Hematol 2010; 73: 185-191.
17. Eto K, Eda K, Hayano M, Goto S, Nagao K, Kawasaki T et al. Reduced expression of an RNA-binding protein prolactin leads to translational silencing of programmed cell death protein 4 and apoptosis in newt spermatogonia. J Biol Chem 2009; 284: 23260-23271.
18. Fujino R, Tanaka K, Morimatsu M, Tamura K, Kogo H, Hara T. Spermatogonial cell-mediated activation of an IkBz-independent nuclear factor-kB pathway in Sertoli cells induces transcription of the lipocalin-2 gene. Mol Endocrinol 2006; 20: 904-915.
19. Dorrello NV, Peschiaroli A, Guardavaccaro D, Colburn NH, Sherman NE, Pagano M. S6K1-and bTRCP-mediated degradation of PDCD4 promotes protein translation and cell growth. Science 2006; 314: 467-471. (Pubitemid 44628968)
20. Giuliano M, D'Anneo A, DeBlasio A, Vento R, Tesoriere G. Apoptosis meets proteasome, an invaluable therapeutic target of anticancer drugs. Ital J Biochem 2003; 52: 112-121.
21. Watanabe T, Takeda A, Mise K, Okuno K, Suzuki T, Minami N et al. Stage-specific expression of microRNAs during Xenopus development. FEBS Lett 2005; 579: 318-324. (Pubitemid 40092406)
22. Shi R, Chiang VL. Facile means for quantifying microRNA expression by real-time PCR. BioTechniques 2005; 39: 519-525.
23. Young MR, Santhanam AN, Yoshikawa N, Colburn NH. Have tumor suppressor PDCD4 and its counteragent oncogenic miR-21 gone rogue? Mol Interv 2010; 10: 76-79.
24. Bitomsky N, Wethkamp N, Marikkannu R, Klempnauer K-H. siRNA-mediated knockdown of Pdcd4 expression causes upregulation of p21(Waf1/Cip1) expression. Oncogene 2008; 27: 4820-4829.
25. Lankat-Buttgereit B, Lenschen B, Schmidt H, Göke R. The action of Pdcd4 may be cell type specific: evidence that reduction of dUTPase levels might contribute to its tumor suppressor activity in Bon-1 cells. Apoptosis 2008; 13: 157-164.
26. Fernandes-Alnemri T, Litwack G, Alnemri ES. CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1b-converting enzyme. J Biol Chem 1994; 269: 30761-30764. (Pubitemid 24377553)
27. Kalinichenko SV, Kopantzev EP, Korobko EV, Palgova IV, Zavalishina LE, Bateva MV et al. Pdcd4 protein and mRNA level alternations do not correlate in human lung tumors. Lung Cancer 2008; 62: 173-180.
28. Chen Y, Knösel T, Kristiansen G, Pietas A, Garber ME, Matsuhashi S et al. Loss of PDCD4 expression in human lung cancer correlates with tumor progression and prognosis. J Pathol 2003; 200: 640-646. (Pubitemid 36987314)
29. Yoshinaga H, Matsuhashi S, Fujiyama C, Masaki Z. Novel human PDCD4 (H731) gene expressed in proliferative cells is expressed in small duct epithelial cells of the breast as revealed by an anti-H731 antibody. Pathol Int 1999; 49: 1067-1077. (Pubitemid 30193505)
30. Afonja O, Juste D, Das S, Matsuhashi S, Samuels HH. Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Evidence for a role in apoptosis. Oncogene 2004; 23: 8135-8145. (Pubitemid 39531854)
31. Göke R, Gregel C, Göke A, Arnold R, Schmidt H, Lankat-Buttgereit B. Programmed cell death 4 (PDCD4) acts as a tumor suppressor in neuroendocrine tumor cells. Ann N Y Acad Sci 2004; 1014: 220-221. (Pubitemid 38594809)
32. Yang HS, Matthews CP, Clair T, Wang Q, Baker AR, Li CC et al. Tumorigenesis suppressor Pdcd4 down-regulates mitogen-activated protein kinase kinase kinase kinase 1 expression to suppress colon carcinoma cell invasion. Mol Cell Biol 2006; 26: 1297-1306. (Pubitemid 43202557)
33. Zhang H, Ozaki I, Mizuta T, Hamajima H, Yasutake T, Eguchi Y et al. Involvement of programmed cell death 4 in transforming growth factor-b1-induced apoptosis in human hepatocellular carcinoma. Oncogene 2006; 25: 6101-6112. (Pubitemid 44562408)
34. Davis BN, Hiyard AC, Lagna G, Hata A. Smad proteins control DROSHA-mediated microRNA maturation. Nature 2008; 454: 56-61. (Pubitemid 351931982)
35. Wang W, Zhao J, Wang H, Sun Y, Peng Z, Zhou G et al. Programmed cell death 4 (PDCD4) mediates the sensitivity of gastric cancer cells to TRAIL-induced apoptosis by down-regulation of FLIP expression. Exp Cell Res 2010; 316: 2456-2464.
36. van de Wetering M, Oving I, Muncan V, Pon Fong MT, Brantjes H, van Leenen D et al. Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector. EMBO Rep 2003; 4: 609-615. (Pubitemid 36939953)